Two Sigma Investments, LP Merck & Co., Inc. Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 2,200,701 shares of MRK stock, worth $168 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

2,200,701

Previous 1,928,829 14.1%

Holding current value

$168 Million

Previous $192 Million 2.95%

% of portfolio

0.46%

Previous 0.46%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$83.01 - $101.02 $22.6 Million - $27.5 Million	271,872 Added 14.1%	2,200,701 $198 Million
Q4 2024 Feb 14, 2025	SELL	$96.31 - $114.76 $780,496 - $930,015	-8,104 Reduced 0.42%	1,928,829 $192 Million
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $50.4 Million - $58.5 Million	453,831 Added 30.6%	1,936,933 $220 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $108 Million - $116 Million	871,699 Added 142.57%	1,483,102 $184 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $183 Million - $213 Million	-1,616,116 Reduced 72.55%	611,403 $80.7 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $133 Million - $145 Million	1,329,341 Added 148.0%	2,227,519 $243 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $92.5 Million - $103 Million	898,178 New	898,178 $92.5 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $19.2 Million - $21.6 Million	227,665 Added 523.96%	271,116 $23.3 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $244 Million - $277 Million	-2,927,708 Reduced 98.54%	43,451 $3.96 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $4.67 Million - $5.23 Million	63,512 Added 2.18%	2,971,159 $244 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $6.8 Million - $8.52 Million	-94,140 Reduced 3.14%	2,907,647 $223 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $13.6 Million - $15 Million	-190,330 Reduced 5.96%	3,001,787 $225 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $53.5 Million - $59.1 Million	760,468 Added 31.27%	3,192,117 $248 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $42 Million - $49.4 Million	-609,270 Reduced 20.04%	2,431,649 $187 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $12.9 Million - $14.3 Million	-179,046 Reduced 5.56%	3,040,919 $249 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $87.5 Million - $99.2 Million	1,195,391 Added 59.04%	3,219,965 $267 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $15.6 Million - $17.8 Million	221,750 Added 12.3%	2,024,574 $157 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $72.6 Million - $101 Million	-1,146,066 Reduced 38.86%	1,802,824 $139 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $116 Million - $131 Million	1,500,233 Added 103.56%	2,948,890 $268 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $105 Million - $115 Million	1,381,766 Added 2065.7%	1,448,657 $122 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $2.34 Million - $2.73 Million	33,467 Added 100.13%	66,891 $5.61 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $2.18 Million - $2.53 Million	33,424 New	33,424 $2.55 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $89.6 Million - $105 Million	-1,552,363 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $141 Million - $165 Million	-2,764,248 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $65.3 Million - $75.9 Million	1,281,742 Added 86.46%	2,764,248 $151 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $38 Million - $45.4 Million	-736,949 Reduced 33.2%	1,482,506 $83.4 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $130 Million - $140 Million	2,219,455	2,219,455 $142 Million

Others Institutions Holding MRK

# of Institutions

3,893

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $193B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Merck & Co., Inc. Transaction History